Viewing Study NCT07211633


Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2026-01-21 @ 1:00 AM
Study NCT ID: NCT07211633
Status: RECRUITING
Last Update Posted: 2025-11-28
First Post: 2025-10-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in Participants With Relapsing Multiple Sclerosis (RMS)
Sponsor: TG Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module